Atyr Pharma Total Current Liabilities

Atyr Pharma (ATYR) currently reports a total current liabilities of $16M as of September 2026. That compares with $16M in the prior-year period — up 5.0% year over year. Use the charts on this page to explore Atyr Pharma's total current liabilities history and peer comparisons.

Atyr Pharma's total current liabilities increased from $16M to $16M — a 5.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Atyr Pharma reported $16M in total current liabilities as of September 2026. That compares with $16M in the prior-year period — up 5.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Atyr Pharma, and consider following ATYR for alerts when major investors trade the stock.

Atyr Pharma is classified in the Healthcare sector. On total current liabilities, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATYR with unrelated industries.